205 related articles for article (PubMed ID: 37812992)
1. Core-shell inorganic NP@MOF nanostructures for targeted drug delivery and multimodal imaging-guided combination tumor treatment.
Khan S; Falahati M; Cho WC; Vahdani Y; Siddique R; Sharifi M; Jaragh-Alhadad LA; Haghighat S; Zhang X; Ten Hagen TLM; Bai Q
Adv Colloid Interface Sci; 2023 Nov; 321():103007. PubMed ID: 37812992
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review.
Karami A; Mohamed O; Ahmed A; Husseini GA; Sabouni R
Anticancer Agents Med Chem; 2021; 21(18):2487-2504. PubMed ID: 33463479
[TBL] [Abstract][Full Text] [Related]
3. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics.
Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C
Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415
[TBL] [Abstract][Full Text] [Related]
4. Electrochemical aptasensor based on the engineered core-shell MOF nanostructures for the detection of tumor antigens.
Khan S; Cho WC; Sepahvand A; Haji Hosseinali S; Hussain A; Nejadi Babadaei MM; Sharifi M; Falahati M; Jaragh-Alhadad LA; Ten Hagen TLM; Li X
J Nanobiotechnology; 2023 Apr; 21(1):136. PubMed ID: 37101280
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional nanoparticle@MOF core-shell nanostructures.
Liu Y; Tang Z
Adv Mater; 2013 Oct; 25(40):5819-25. PubMed ID: 24038572
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable Metal Organic Frameworks for Multimodal Imaging and Targeting Theranostics.
Lai X; Jiang H; Wang X
Biosensors (Basel); 2021 Aug; 11(9):. PubMed ID: 34562889
[TBL] [Abstract][Full Text] [Related]
7. Design of Raman tag-bridged core-shell Au@Cu
He J; Dong J; Hu Y; Li G; Hu Y
Nanoscale; 2019 Mar; 11(13):6089-6100. PubMed ID: 30869726
[TBL] [Abstract][Full Text] [Related]
8. Biomedical application of metal-organic frameworks (MOFs) in cancer therapy: Stimuli-responsive and biomimetic nanocomposites in targeted delivery, phototherapy and diagnosis.
Li B; Ashrafizadeh M; Jiao T
Int J Biol Macromol; 2024 Mar; 260(Pt 2):129391. PubMed ID: 38242413
[TBL] [Abstract][Full Text] [Related]
9. Nanoscale metal-organic frameworks as key players in the context of drug delivery: evolution toward theranostic platforms.
Carrillo-Carrión C
Anal Bioanal Chem; 2020 Jan; 412(1):37-54. PubMed ID: 31734711
[TBL] [Abstract][Full Text] [Related]
10. Smart Delivery Systems Based on Poly(glycidyl methacrylate)s-Coated Organic/Inorganic Core-Shell Nanohybrids.
Tan LL; Shang L
Macromol Rapid Commun; 2019 Sep; 40(17):e1800879. PubMed ID: 30817069
[TBL] [Abstract][Full Text] [Related]
11. Stimuli-Responsive Design of Metal-Organic Frameworks for Cancer Theranostics: Current Challenges and Future Perspective.
Pantwalawalkar J; Mhettar P; Nangare S; Mali R; Ghule A; Patil P; Mohite S; More H; Jadhav N
ACS Biomater Sci Eng; 2023 Aug; 9(8):4497-4526. PubMed ID: 37526605
[TBL] [Abstract][Full Text] [Related]
12. Metal-Organic Framework in Pharmaceutical Drug Delivery.
Kundu S; Swaroop AK; Selvaraj J
Curr Top Med Chem; 2023; 23(13):1155-1170. PubMed ID: 36733193
[TBL] [Abstract][Full Text] [Related]
13. Engineering Phototheranostic Nanoscale Metal-Organic Frameworks for Multimodal Imaging-Guided Cancer Therapy.
Cai W; Gao H; Chu C; Wang X; Wang J; Zhang P; Lin G; Li W; Liu G; Chen X
ACS Appl Mater Interfaces; 2017 Jan; 9(3):2040-2051. PubMed ID: 28032505
[TBL] [Abstract][Full Text] [Related]
14. Coupling metal organic frameworks with molybdenum disulfide nanoflakes for targeted cancer theranostics.
Yang S; Li D; Chen L; Zhou X; Fu L; You Y; You Z; Kang L; Li M; He C
Biomater Sci; 2021 May; 9(9):3306-3318. PubMed ID: 33459315
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable Core-shell Dual-Metal-Organic-Frameworks Nanotheranostic Agent for Multiple Imaging Guided Combination Cancer Therapy.
Wang D; Zhou J; Shi R; Wu H; Chen R; Duan B; Xia G; Xu P; Wang H; Zhou S; Wang C; Wang H; Guo Z; Chen Q
Theranostics; 2017; 7(18):4605-4617. PubMed ID: 29158848
[TBL] [Abstract][Full Text] [Related]
16. Theranostic metal-organic framework core-shell composites for magnetic resonance imaging and drug delivery.
Zhao HX; Zou Q; Sun SK; Yu C; Zhang X; Li RJ; Fu YY
Chem Sci; 2016 Aug; 7(8):5294-5301. PubMed ID: 30155180
[TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment.
Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y
Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202
[TBL] [Abstract][Full Text] [Related]
18. Recent advances of the core-shell MOFs in tumour therapy.
Zeng Y; Xu G; Kong X; Ye G; Guo J; Lu C; Nezamzadeh-Ejhieh A; Shahnawaz Khan M; Liu J; Peng Y
Int J Pharm; 2022 Nov; 627():122228. PubMed ID: 36162610
[TBL] [Abstract][Full Text] [Related]
19. Core-shell metal-organic frameworks with fluorescence switch to trigger an enhanced photodynamic therapy.
Liu Y; Gong CS; Lin L; Zhou Z; Liu Y; Yang Z; Shen Z; Yu G; Wang Z; Wang S; Ma Y; Fan W; He L; Niu G; Dai Y; Chen X
Theranostics; 2019; 9(10):2791-2799. PubMed ID: 31244923
[TBL] [Abstract][Full Text] [Related]
20. Facile Regulation of Shell Thickness of the Au@MOF Core-Shell Composites for Highly Sensitive Surface-Enhanced Raman Scattering Sensing.
Li B; Liu Y; Cheng J
Sensors (Basel); 2022 Sep; 22(18):. PubMed ID: 36146388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
